Immunity's fourth dimension: Approaching the circadian-immune connection

Trends in Immunology

Volumn 33, Issue 12, 2012, Pages 607-612

  Arjona, Alvaro ^a,b   Silver, Adam C ^a   Walker, Wendy E ^a,c   Fikrig, Erol ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THOMSON REUTERS   (United Kingdom)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Circadian; Daily rhythms; Immunity

Indexed keywords

PATTERN RECOGNITION RECEPTOR; PROTEIN BMAL1; TRANSCRIPTION FACTOR CLOCK;

CD4+ T LYMPHOCYTE; CIRCADIAN RHYTHM; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INNATE IMMUNITY; MOLECULAR BIOLOGY; NATURAL KILLER CELL; NONHUMAN; REVIEW;

ANIMALS; CELL COMMUNICATION; CIRCADIAN RHYTHM; HUMANS; IMMUNE SYSTEM; MODELS, IMMUNOLOGICAL;

EID: 84869747579     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2012.08.007     Document Type: Review

References (63)

1. Dibner C., et al. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu. Rev. Physiol. 2010, 72:517-549.
2. Lange T., et al. Effects of sleep and circadian rhythm on the human immune system. Ann. N. Y. Acad. Sci. 2010, 1193:48-59.
3. Cutolo M. Chronobiology and the treatment of rheumatoid arthritis. Curr. Opin. Rheumatol. 2012, 24:312-318.
4. Greene M.W. Circadian rhythms and tumor growth. Cancer Lett. 2012, 318:115-123.
5. Roden L.C., Ingle R.A. Lights, rhythms, infection: the role of light and the circadian clock in determining the outcome of plant-pathogen interactions. Plant Cell 2009, 21:2546-2552.
6. Stone E.F., et al. The circadian clock protein timeless regulates phagocytosis of bacteria in Drosophila. PLoS Pathog. 2012, 8:e1002445.
7. Christoph Scheiermann Y.K., et al. Adrenergic nerves govern circadian leukocyte recruitment to tissues. Immunity 2012, 37:290-301.
8. Narasimamurthy R., et al. Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:12662-12667.
9. Silver A.C., et al. The circadian clock controls toll-like receptor 9-mediated innate and adaptive immunity. Immunity 2012, 36:251-261.
10. Reppert S.M., Weaver D.R. Coordination of circadian timing in mammals. Nature 2002, 418:935-941.
11. Bellet M.M., Sassone-Corsi P. Mammalian circadian clock and metabolism - the epigenetic link. J. Cell Sci. 2010, 123:3837-3848.
12. Arjona A., Sarkar D.K. The circadian gene mPer2 regulates the daily rhythm of IFN-gamma. J. Interferon Cytokine Res. 2006, 26:645-649.
13. Arjona A., Sarkar D.K. Are circadian rhythms the code of hypothalamic-immune communication? Insights from natural killer cells. Neurochem. Res. 2008, 33:708-718.
14. Thoennissen N.H., et al. Transcription factor CCAAT/enhancer-binding protein alpha and critical circadian clock downstream target gene PER2 are highly deregulated in diffuse large B-cell lymphoma. Leuk. Lymphoma 2012, 53:1577-1585.
15. Miyazaki K., et al. Tumor growth suppression in vivo by overexpression of the circadian component, PER2. Genes Cells 2010, 15:351-358.
16. Luo Y., et al. Expression profiling reveals a positive regulation by mPer2 on circadian rhythm of cytotoxicity receptors: Ly49C and Nkg2d. Chronobiol. Int. 2009, 26:1514-1544.
17. Liu A.C., et al. Redundant function of REV-ERBalpha and beta and non-essential role for Bmal1 cycling in transcriptional regulation of intracellular circadian rhythms. PLoS Genet. 2008, 4:e1000023.
18. Gibbs J.E., et al. The nuclear receptor REV-ERBalpha mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:582-587.
19. Yamajuku D., et al. Cellular DBP and E4BP4 proteins are critical for determining the period length of the circadian oscillator. FEBS Lett. 2011, 585:2217-2222.
20. Male V., et al. E4BP4: an unexpected player in the immune response. Trends Immunol. 2012, 33:98-102.
21. Hashiramoto A., et al. Mammalian clock gene Cryptochrome regulates arthritis via proinflammatory cytokine TNF-alpha. J. Immunol. 2010, 184:1560-1565.
22. Lee J.H., Sancar A. Regulation of apoptosis by the circadian clock through NF-kappaB signaling. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:12036-12041.
23. Petrzilka S., et al. Clock gene modulation by TNF-alpha depends on calcium and p38 MAP kinase signaling. J. Biol. Rhythms 2009, 24:283-294.
24. Cavadini G., et al. TNF-alpha suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:12843-12848.
25. Bhardwaj V., et al. Defence responses of Arabidopsis thaliana to infection by Pseudomonas syringae are regulated by the circadian clock. PLoS ONE 2011, 6:e26968.
26. Wang W., et al. Timing of plant immune responses by a central circadian regulator. Nature 2011, 470:110-114.
27. Keller M., et al. A circadian clock in macrophages controls inflammatory immune responses. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:21407-21412.
28. Mazzoccoli G., et al. Time-related dynamics of variation in core clock gene expression levels in tissues relevant to the immune system. Int. J. Immunopathol. Pharmacol. 2011, 24:869-879.
29. Logan R.W., et al. Role of sympathetic nervous system in the entrainment of circadian natural-killer cell function. Brain Behav. Immun. 2012, 25:101-109.
30. Silver A.C., et al. Circadian expression of clock genes in mouse macrophages, dendritic cells, and B cells. Brain Behav. Immun. 2012, 26:407-413.
31. Mendez-Ferrer S., et al. Haematopoietic stem cell release is regulated by circadian oscillations. Nature 2008, 452:442-447.
32. Dimitrov S., et al. Cortisol and epinephrine control opposing circadian rhythms in T cell subsets. Blood 2009, 113:5134-5143.
33. Mazzoccoli G., et al. Circadian rhythmicity of lymphocyte subpopulations and relationship with neuro-endocrine system. J. Biol. Regul. Homeost. Agents 2010, 24:341-350.
34. Mazzoccoli G., et al. A timetable of 24-hour patterns for human lymphocyte subpopulations. J. Biol. Regul. Homeost. Agents 2011, 25:387-395.
35. Bollinger T., et al. Circadian clocks in mouse and human CD4+ T cells. PLoS ONE 2011, 6:e29801.
36. Fortier E.E., et al. Circadian variation of the response of T cells to antigen. J. Immunol. 2011, 187:6291-6300.
37. Alten R. Chronotherapy with modified-release prednisone in patients with rheumatoid arthritis. Expert Rev. Clin. Immunol. 2012, 8:123-133.
38. Alten R., et al. Hypothalamus-pituitary-adrenal axis function in patients with rheumatoid arthritis treated with nighttime-release prednisone. J. Rheumatol. 2010, 37:2025-2031.
39. Mouterde G., et al. Predictors of radiographic progression in the ESPOIR cohort: the season of first symptoms may influence the short-term outcome in early arthritis. Ann. Rheum. Dis. 2011, 70:1251-1256.
40. Slats D., et al. Reciprocal interactions between sleep, circadian rhythms and Alzheimer's disease: focus on the role of hypocretin and melatonin. Ageing Res. Rev. 2012, [Epub ahead of print].
41. Kang J.E., et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 2009, 326:1005-1007.
42. Moghekar A., et al. Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort. Arch. Neurol. 2012, 69:246-250.
43. Hrushesky W.J., Wood P.A. Circadian time structure of septic shock: timing is everything. J. Infect. Dis. 1997, 175:1283-1284.
44. Scheer F.A., et al. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4453-4458.
45. Straif K., et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 2007, 8:1065-1066.
46. Pan A., et al. Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women. PLoS Med. 2011, 8:e1001141.
47. Brown D.L., et al. Rotating night shift work and the risk of ischemic stroke. Am. J. Epidemiol. 2009, 169:1370-1377.
48. Hoffman A.E., et al. Clock-cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2. Cancer Res. 2009, 69:3605-3613.
49. Carlson D.E., Chiu W.C. The absence of circadian cues during recovery from sepsis modifies pituitary-adrenocortical function and impairs survival. Shock 2008, 29:127-132.
50. Mazzoccoli G., et al. Altered expression of the clock gene machinery in kidney cancer patients. Biomed. Pharmacother. 2012, 66:175-179.
51. Mazzoccoli G., et al. Chronodisruption in lung cancer and possible therapeutic approaches. Biomed. Pharmacother. 2011, 65:500-508.
52. Mazzoccoli G., et al. Altered time structure of neuro-endocrine-immune system function in lung cancer patients. BMC Cancer 2010, 10:314.
53. Mundigler G., et al. Impaired circadian rhythm of melatonin secretion in sedated critically ill patients with severe sepsis. Crit. Care Med. 2002, 30:536-540.
54. Verceles A.C., et al. Circadian rhythm disruption in severe sepsis: the effect of ambient light on urinary 6-sulfatoxymelatonin secretion. Intensive Care Med. 2012, 38:804-810.
55. Flierl M.A., et al. Disturbances of the hypothalamic-pituitary-adrenal axis and plasma electrolytes during experimental sepsis. Ann. Intensive Care 2011, 1:53.
56. Carlson D.E., et al. Cecal ligation and puncture in rats interrupts the circadian rhythms of corticosterone and adrenocortical responsiveness to adrenocorticotrophic hormone. Crit. Care Med. 2006, 34:1178-1184.
57. Baracchi F., et al. Sepsis-induced alterations in sleep of rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 301:R1467-R1478.
58. Vollmer J., Krieg A.M. Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists. Adv. Drug Deliv. Rev. 2009, 61:195-204.
59. Jetten A.M. Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl. Recept. Signal. 2009, 7:e003.
60. O'Neill J.S., Reddy A.B. Circadian clocks in human red blood cells. Nature 2011, 469:498-503.
61. Logan R.W., et al. Chronic shift-lag alters the circadian clock of NK cells and promotes lung cancer growth in rats. J. Immunol. 2012, 188:2583-2591.
62. Levi F., Okyar A. Circadian clocks and drug delivery systems: impact and opportunities in chronotherapeutics. Expert Opin. Drug Deliv. 2011, 8:1535-1541.
63. Dallmann R., et al. The human circadian metabolome. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:2625-2629.